2018
DOI: 10.1016/j.jcin.2018.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
50
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 67 publications
(52 citation statements)
references
References 18 publications
2
50
0
Order By: Relevance
“…Though the surge of TAVR has led to a reduction in isolated SAVR volume, SAVR is still an option for low-risk patients. 1,5,6,12 It is the low risk/younger patients that are more likely to need a valve reintervention during their lifetime. Hence, shared decision making between the patient and heart team is essential in patients with high-risk anatomy to discuss all options for lifetime management.…”
Section: Discussionmentioning
confidence: 99%
“…Though the surge of TAVR has led to a reduction in isolated SAVR volume, SAVR is still an option for low-risk patients. 1,5,6,12 It is the low risk/younger patients that are more likely to need a valve reintervention during their lifetime. Hence, shared decision making between the patient and heart team is essential in patients with high-risk anatomy to discuss all options for lifetime management.…”
Section: Discussionmentioning
confidence: 99%
“…Though the surge of TAVR has led to a reduction in isolated SAVR volume, SAVR is still an option for low-risk patients. (1,9) It is the low risk/younger patients that are more likely to need a valve re-intervention during their lifetime. Hence, shared decision making between the patient and heart team is essential in patients with high risk anatomy to discuss all options for lifetime management.…”
Section: Discussionmentioning
confidence: 99%
“…Transcatheter aortic valve replacement (TAVR) is increasingly considered the standard of care in patients with symptomatic aortic stenosis across the spectrum of surgical risk provided there has been an evaluation by the Heart Team and consideration of anatomic and comorbid conditions 1‐5 . In light of patient preference for TAVR, as well as several randomized‐controlled trials showing similar short and midterm outcomes across spectrums of risk, TAVR has now eclipsed surgical aortic valve replacement (SAVR) worldwide as the predominant treatment for severe aortic stenosis 6,7 …”
Section: Introductionmentioning
confidence: 99%